These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18727952)

  • 1. Selective resistance of taurine-fed mice to isoniazide-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase.
    El Idrissi A; L'Amoreaux WJ
    Neuroscience; 2008 Oct; 156(3):693-9. PubMed ID: 18727952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemic patients?
    Malfatti CR; Perry ML; Schweigert ID; Muller AP; Paquetti L; Rigo FK; Fighera MR; Garrido-Sanabria ER; Mello CF
    Neuroscience; 2007 Jun; 146(4):1879-87. PubMed ID: 17467181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of GABAA receptors in taurine-fed mice.
    L'Amoreaux WJ; Marsillo A; El Idrissi A
    J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S14. PubMed ID: 20804588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological Evidence for Anti-epileptic Property of Taurine.
    Shukurova S; Sadek R; Mekawy N; Bendaoud M; Yachou Y; Mamchyn A; El Idrissi A
    Adv Exp Med Biol; 2022; 1370():333-340. PubMed ID: 35882808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteinesulfinate decarboxylase activity as an index of taurine-containing structures.
    Staines WA; Benjamin AM; McGeer EG
    J Neurosci Res; 1980; 5(6):555-62. PubMed ID: 7205993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced seizures in taurine-deficient mice].
    Shimada C; Tanaka S; Sano M; Araki H
    Yakubutsu Seishin Kodo; 1991 Aug; 11(4):257-60. PubMed ID: 1799096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.
    Thompson M; Weickert CS; Wyatt E; Webster MJ
    J Psychiatr Res; 2009 Jul; 43(11):970-7. PubMed ID: 19321177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of taurine on seizures induced by 4-aminopyridine.
    Pasantes-Morales H; Arzate ME
    J Neurosci Res; 1981; 6(4):465-74. PubMed ID: 7299851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine improves learning and retention in aged mice.
    El Idrissi A
    Neurosci Lett; 2008 May; 436(1):19-22. PubMed ID: 18375059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anticonvulsant activity of QUAN-0806 in various murine experimental seizure models.
    Guan LP; Zhao DH; Jiang Z; Piao HR; Quan ZS
    Pharmazie; 2009 Apr; 64(4):248-51. PubMed ID: 19435143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antisense glutamic acid decarboxylase oligodeoxynucleotide on epileptic rats induced by pentylenetetrazol.
    He X; Wang W; Ruan X; Li W; Zhang L
    Chin Med J (Engl); 2002 Mar; 115(3):425-9. PubMed ID: 11940381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic acid decarboxylase 65, 67, and GABA-transaminase mRNA expression and total enzyme activity in the goldfish (Carassius auratus) brain.
    Martyniuk CJ; Awad R; Hurley R; Finger TE; Trudeau VL
    Brain Res; 2007 May; 1147():154-66. PubMed ID: 17362888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apocalmodulin on recombinant human brain glutamic acid decarboxylase.
    Jin H; Sha D; Wei J; Davis KM; Wu H; Jin Y; Wu JY
    J Neurochem; 2005 Feb; 92(4):739-48. PubMed ID: 15686475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranigral transplants of immortalized GABAergic cells decrease the expression of kainic acid-induced seizures in the rat.
    Castillo CG; Mendoza S; Freed WJ; Giordano M
    Behav Brain Res; 2006 Jul; 171(1):109-15. PubMed ID: 16677720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of some xanthone derivatives.
    Rajtar G; Zółkowska D; Kleinrok Z; Marona H
    Acta Pol Pharm; 1999; 56(4):311-8. PubMed ID: 10635365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gene expression at inhibitory synapses in response to taurine treatment.
    Shen CH; Lempert E; Butt I; Neuwirth LS; Yan X; El Idrissi A
    Adv Exp Med Biol; 2013; 775():187-94. PubMed ID: 23392935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1.
    Garcia-Garcia AL; Elizalde N; Matrov D; Harro J; Wojcik SM; Venzala E; Ramírez MJ; Del Rio J; Tordera RM
    Biol Psychiatry; 2009 Aug; 66(3):275-82. PubMed ID: 19409534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of epilepsy by taurine treatments in mice experimental model.
    Junyent F; Utrera J; Romero R; Pallàs M; Camins A; Duque D; Auladell C
    J Neurosci Res; 2009 May; 87(6):1500-8. PubMed ID: 19025770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice.
    Tripathi PP; Sgadò P; Scali M; Viaggi C; Casarosa S; Simon HH; Vaglini F; Corsini GU; Bozzi Y
    Neuroscience; 2009 Mar; 159(2):842-9. PubMed ID: 19186208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coumarin effects on amino acid levels in mice prefrontal cortex and hippocampus.
    Pereira EC; Lucetti DL; Barbosa-Filho JM; de Brito EM; Monteiro VS; Patrocínio MC; de Moura RR; Leal LK; Macedo DS; de Sousa FC; de Barros Viana GS; Vasconcelos SM
    Neurosci Lett; 2009 Apr; 454(2):139-42. PubMed ID: 19429071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.